Volume 121, Issue 3 , Pages 603-606, March 2008
Usefulness and optimization of mouse models of allergic airway disease
No abstract is available. To read the body of this article, please view the Full Text online.
Supported by the Department of Veterans Affairs and the National Heart, Lung, and Blood Institute (P01 HL076383 and RO1 HL67736).
Disclosure of potential conflict of interest: F. D. Finkelman has consulting arrangements with Amgen, Abbott, Peptimmune, and Schering-Plough; has received research support from Plexxikon; is an associate editor of The Journal of Allergy and Clinical Immunology; and is on the board of directors for FASEB. M. Wills-Karp has served as a member of the American Association of Immunologists.
PII: S0091-6749(08)00137-1
doi:10.1016/j.jaci.2008.01.008
© 2008 American Academy of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights reserved.
Volume 121, Issue 3 , Pages 603-606, March 2008
